Anal Cancer Therapeutics Market : Global Industry Analysis and Forecast 2016 - 2024

Transcription

Anal Cancer Therapeutics Market : Global Industry Analysis
and Forecast 2016 - 2024
Persistence Market Research
Anal Cancer Therapeutics Market : Global
Industry Analysis and Forecast 2016 - 2024
1
Persistence Market Research Released New Market Report on “Anal Cancer Therapeutics
Market : Global Industry Analysis and Forecast 2016 - 2024”.
A cancer can be defined when the normal cells lose their ability to control, their growth or
multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often
called as squamous cell carcinoma which arises from the cells around or in the anal opening or
in rare cases it may cause in the anal canal. This type of cancer is usually associated with
human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of
developing into anal cancer. There are no exact symptoms for anal cancer as such but some
might show bleeding from the anal area, lump or swelling near anus or change in the bowel
habits etc. Staging is a way which describes the location of cancer, the stages include tumor,
node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal
cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.
Interested in report: Please follow the below links to meet your requirements; Request
for the Report Sample: http://www.persistencemarketresearch.com/samples/10658
The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer
diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the
market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple
sexual partners and smoking. According to the World Health Organization 290 million women
are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For
treating this anal cancer, early diagnosis is crucial which is only available in the developed
countries or high-income countries and are accessible. Whereas in the low-income countries the
diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible
for holding back the anal cancer therapeutics market and should be well tracked for future
advancements.
2
The anal cancer therapeutics market can be classified on the basis of product type and
distribution channel.
According to the product type, the anal cancer therapeutics can be sun-divided into the
following:

Chemotherapy drugs

Fluorouracil

Cisplatin

Carboplatin
According to the distribution channel, the anal cancer therapeutics can be sun-divided
into the following:

Hospitals

Long-term care centers

Pharmacies

Diagnostic Laboratories
Altogether 80% of anal cancers are developed after the age of 60 and the ones which occur
prior to age 35 are mostly observed in men. Almost half of the anal caners are diagnosed before
the cancer turns to be malignant but when the cancer is found through early diagnosis are
treatable. The survival rate of anal cancer in male is 60% and 70% in female for 5 years. Most
of the anal cancers are treated with combination therapy and some are treated with surgery
3
when early diagnosed. Cancer treatment includes chemotherapy, radiation therapy and surgery
which is also dependent on the stage of the tumor.
Worldwide there are 1 or 2 cases per 100000 cases and accounts for about 1.5 % of the cases
in the United States. Anal cancer therapeutics market share is more in North America followed
by Europe. In U.K the incidence cases did not grow in the past few years and thus the anal
cancer accounts for less than 1% of all the deaths. In the developed countries and developing
countries several epidemiologic studies have found out that the chances for developing anal
cancer can be directly related to sexual practices. Also the number of the sexually transmitted
diseases has increased over the past couple of years leading to rise in the number of diseases
and infections. The developed countries have proper healthcare facilities and thus treatment for
anal cancer is possible.
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/10658
The major market players in the anal cancer therapeutics are GlaxoSmithKline Pharmaceuticals
Ltd., Spectrum Pharmaceuticals, Inc., Hospira, Inc., Global BioPharma, Inc., and Advaxis, Inc.
The report covers exhaustive analysis on:

Anal Cancer Therapeutics Market Segments

Anal Cancer Therapeutics Market Dynamics

Historical Actual Market Size, 2013 - 2015

Anal Cancer Therapeutics Market Size & Forecast 2016 to 2022

Anal Cancer Therapeutics Current Trends/Issues/Challenges
4

Competition & Companies involved

Anal Cancer Therapeutics Drivers and Restraints
Regional analysis includes

North America

Latin America

Europe

Asia Pacific

Middle East & Africa
Report Highlights:

Shifting Industry dynamics

In-depth market segmentation

Historical, current and projected industry size Recent industry trends

Key Competition landscape

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance
5
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multidisciplinary approach. At PMR, we unite various data streams from multi-dimensional sources.
By deploying real-time data collection, big data, and customer experience analytics, we deliver
business intelligence for organizations of all sizes.
Contact Us:
305 Broadway,
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
6

Anal Cancer Therapeutics Market : Global Industry Analysis and Forecast 2016 - 2024

Transcription

Similar documents

Anal Sex PART 1: DECISIONS

Fact Sheet - Anal Play

It's what's inside that counts: very true with B BALLS... FACTORY!

Companies in Stealth Mode

Sexual Pleasure Series

Janice Reid Continence Services Manager Western Health & Social Care Trust

TEMPO ®

The Art of the Blowjob Babeland University